Nationally Recognized Heart Hospital
Dallas | Fort Worth




Find a Physician

Advanced Search

Publications

About Us

Staying abreast of new technology and diagnostic as well as treatment options for our patients is a high priority at Baylor Jack and Jane Hamilton Heart and Vascular Hospital. Our goal is to develop and be involved in advanced research of the highest integrity that will allow our patients to participate in and benefit from innovative heart and vascular discoveries. Research is the backbone and first step in defining patient care. The 75-plus trials we are currently running are investigating many areas, including an anticoagulant that does not require INR bloodwork, genes and angina, atrial fibrillation, and stenting of the left main coronary artery.

The physicians on our medical staff and clinical staff members have been published in numerous journals and books, on topics ranging from atrial septal defects to congestive heart failure to angiography. Recent articles are included below:

Comparative Efficacy of Transradial Versus Transfemoral Approach for Coronary Angiography and Percutaneous Coronary Intervention

Jeffrey M. Schussler, MD, Anupama Vasudevan, BDS, MPH, PhD, Liana J. von Bose, BA, Jane I. Won, BS, Peter A. McCullough, MD, MPH
Transradial artery (TRA) approach is associated with fewer vascular complications and reduced mortality in patients at high risk compared with transfemoral approach (TFA). The objective of our study was to compare the characteristics and outcomes of patients who had coronary angiography by TRA and TFA over the course of hospital implementation of this approach.
For full article, click here.

Goal-Directed Heart Failure Care in Patients With Chronic Kidney Disease and End-Stage Renal Disease

Peter A McCullough, MD, MPH, Aasim Afzal, MD, MBA, Parag Kale, MD
Investigators have long recognized that renal function and cardiac performance are integrally linked through hemodynamic, neural, humoral, cell signaling, proteomic, and metabolomic pathways (1). Among risk factors for the development of heart failure (HF), chronic kidney disease (CKD) is the most powerful because it contributes to the three fundamental mechanisms of left ventricular failure: 1) pressure overload; 2) volume overload; and 3) cardiomyopathy (2). When CKD progresses to end-stage renal disease (ESRD), these three mechanisms driving HF become more difficult to control because patients undergoing dialysis have on average higher blood pressures; poor volume control only partially addressed by thrice weekly hemodialysis in most cases; and a well-described form of cardiomyopathy characterized by severe left ventricular hypertrophy, marked cardiac fibrosis, reduced capillary density, and calcific deposits on the mitral and aortic valves (3). None of the goal-directed medical or device therapies proven to reduce HF-related hospitalization and cardiovascular death in the general population with HF have been demonstrated to be effective in patients with ESRD (4).
For full article, click here.

Advanced technology in interventional cardiology: A roadmap for the future of precision coronary interventions

Chad M. Dugas, MD and Jeffrey M. Schussler, MD, FACC, FSCAI
Improving the treatment of patients with cardiovascular disease as well as the safety of the physicians who care for them can potentially be impacted by several new technologies including high-resolution CT coronary imaging with fractional flow reserve, virtual reality, vascular robotic systems, and three-dimensional printing.
For full article, click here.

A review of spontaneous closure of ventricular septal defect

Jun Zhang, MD, MS, Jong Mi Ko, BA, Joseph M. Guileyardo, MD, and
William C. Roberts, MD
Spontaneous closure of VSD can be determined through a variety of methods — echocardiography, Doppler color flow imaging, angiography, auscultation, and cardiac catheterization — and can be proven by pathological evidence at necropsy.
For full article, click here.

Commonalities of Cardiac Rupture (Left Ventricular Free Wall or Ventricular Septum or Papillary Muscle) During Acute Myocardial Infarction Secondary to Atherosclerotic Coronary Artery Disease

William C. Roberts, MD, Kendall H. Burks, Jong Mi Ko, BA, Giovanni Filardo, PhD and Joseph M. Guileyardo, MD
Mortality rates during acute myocardial infarction (AMI) continue to drop, however, cardiac rupture (left ventricular free wall or ventricular septum or papillary muscular or combination) continues to remain relatively common. The aim of this study was to identify commonalities among patients with AMI complicated by cardiac rupture.

High-intensity cardiac rehabilitation training of a commercial pilot who, after percutaneous coronary intervention, wanted to continue participating in a rigorous strength and conditioning program.

Sanjay Shrestha, BS, Jenny Adams, PhD, Anne Lawrence, RN, and Jeffrey M. Schussler, MD
A 64-year-old commercial pilot underwent elective percutaneous coronary intervention, and was then sent to cardiac rehabilitation. He wanted to maintain his rigorous strength and conditioning training and eventually return to being a pilot. A specialized training regimen was designed specifically for his needs, and he was able to resume his life as a commercial pilot. For full article, click here.

An alternative approach to prescribing sternal precautions after median sternotomy, "Keep Your Move in the Tube"

Jenny Adams, PhD, Ana Lotshaw, PT, PhD, CCS, Emelia Exum, PT, DPT, Mark Campbell, BSc, MSc, Cathy B. Spranger, DrPH, Jim Beveridge, RN, PCCN, Shawn Baker, PT, DPT, MS, Stephanie McCray, RN, Tim Bilbrey, MBA, Tiffany Shock, BS, Anne Lawrence, RN, Baron L. Hamman, MD, Jeffrey M. Schussler, MD
Traditional sternal precautions, given to sternotomy patients as part of their discharge education, are intended to help prevent sternal wound complications. Our research team performed a series of studies that measured the forces exerted during various common activities and their relationship to the sternum. The alternative approach that we introduce applies standard kinesiological principles and teaches patients how to perform load-bearing movements in a way that avoids excessive stress to the sternum For full article, click here.

Surviving Malignant Hypertrophic Cardiomyopathy with all Major Complications in a Single Patient.

Barry J. Maron, MD, Henry L. Weiner, MD, Martin S. Maron, MD, William C. Roberts, MD
This publication discusses a 38 year old patient that presented with all three major disease complications of hypertrophic cardiomyopathy and survived as a result of effective treatment modalities available for individuals with the disease. For full article, click here.

Contemporary Review – Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3000 procedures.

Wilber Su, MD, FHRS, Robert Kowal, MD, FHRS, Marcin Kowalski, MD, FHRS, Andreas Metzner, MD, FHRS, J. Thomas Svinarich, MD, FHRS, Kevin Wheelan, MD, FHRS, Paul Wang, MD, FHRS
This study reviews existing best practices regarding cryoballoon ablation in atrial fibrillation to create a user’s consensus guide, providing insight into safer and more effective outcomes for CB2 ablations. For full article, click here.

The Two Extremes of Cardiac Sarcoidosis and the Effect of Prednisone Therapy

Danielle Armstrong, DO, Gonzalo V. Gonzalez-Stawinski, MD, Jong M. Ko, BA, Shelley A. Hall, MD, and William C. Roberts, MD
This article contains the clinical and morphologic findings in two patients who underwent heart transplantation because of severe heart failure as a result of cardiac sarcoidosis. For full article, click here.

Surgical Coronary Revascularization Using an Off-Pump, No-Touch Technique

Jeffrey M. Schussler, Theodore T. Theologes, Baron L. Hamman
For full article, click here.

Screening, Diagnosis, and Management of CAD in Asymptomatic Diabetic Patients*

Peter A. McCullough, Poorya Fazel, James W. Choi
For full article, click here.

The Incidence and Outcome of Endothermal Heat-induced Thrombosis after Endovenous Laser Ablation

Katherine Kane, Tammy Fisher, Monica Bennett, William Shutze Jr, Taylor Hicks, Brad Grimsley, Dennis Gable, Greg Pearl, Bert Smith, and William Shutze Sr, Dallas, Texas
For full article, click here.

Safety and Efficacy of Ixmyelocel-T An Expanded, Autologous Multi-Cellular Therapy, in Dilated Cardiomyopathy

Timothy D. Henry, Jay H. Traverse, Baron L. Hammon, Cara A. East, Brian Bruckner, Ann E. Remmers, David Recker, David A. Bull, Amit N. Patel
For full article, click here.

Advanced technology in interventional cardiology: A roadmap for the future of precision coronary interventions

Chad M. Dugas, MD and Jeffrey M. Schussler, MD, FACC, FSCAI
Improving the treatment of patients with cardiovascular disease as well as the safety of the physicians who care for them can potentially be impacted by several new technologies including high-resolution CT coronary imaging with fractional flow reserve, virtual reality, vascular robotic systems, and three-dimensional printing.

Cardiac Surgery Publicatons

Donor Hearts: Time to Look at Them in a Different Light?

Gonzalo V. Gonzalez-Stawinski, MD
In this edition of The Journal of Cardiac Heart Failure, 2 papers aim to inform readers of donor groups that could be considered at the time of cardiac donation in the hope of expanding the stagnant donor pool.
For full article, click here.

An alternative approach to prescribing sternal precautions after median sternotomy, “Keep Your Move in the Tube”.

Adams J, Lotshaw A, Exum E, Campbell M, Spranger CB, Beveridge J, Baker S, McCray S, Bilbrey T, Shock T, Lawrence A, Hamman BL, Schussler JM.
An alternative approach to prescribing sternal precautions after median sternotomy, “Keep Your Move in the Tube”. Proceedings Baylor University Medical Center 2016; 29(1): 97-100.

Development of a Squamous Cell Carcinoma of the Hand and Wrist After Cardiac Transplantation.

Carey S, Jackson WT, Hitchcock MA, Lima B, Hall S. Development of a Squamous Cell Carcinoma of the Hand and Wrist After Cardiac Transplantation. American Journal of Cardiology 2016; 117(11): 1853-1854.

Excess short-term mortality in women after isolated coronary artery bypass graft surgery.

Filardo G, Hamman BL, Pollock BD, da Graca B, Sass DM, Phan TK, Edgerton J, Prince SL, Ring WS. Excess short-term mortality in women after isolated coronary artery bypass graft surgery. Open Heart 2016; 3(1): e000386.

Donor Hearts: Time to Look at Them in a Different Light

Gonzalez-Stawinski GV. Donor Hearts: Time to Look at Them in a Different Light? Journal of Cardiac Failure 2016; 22(5): 383-384.

Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device.

Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall S. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device. The American Journal of Cardiology 2016; 117(10): 1622-1628.

Invited Commentary: Using “broken hearts” for cardiac transplantation: a risky venture or fruitful endeavor?

Lima B. Invited Commentary: Using “broken hearts” for cardiac transplantation: a risky venture or fruitful endeavor? Proceedings Baylor University Medical Center 2016; 29(1): 74. 75.

The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability.

Loor G, Schuster A, Cruz V, Rafael A, Stewart WJ, Diaz J, McCurry K. The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability. Journal of Cardiothoracic Surgery 2016; Epub.
For full article, click here.

Frequency of Massive Cardiac Adiposity (Floating Heart) in the Native Hearts of Patients Having Heart Transplantation at a Single Texas Hospital (2013 to 2015) and Comparison of Various Clinical and Morphologic Variables in the Patients With Massive Versus Nonmassive Cardiac Adiposity.

Roberts WC, Won VS, Vasudevan A, Ko JM, Hall SA, Gonzalez-Stawinski GV. Frequency of Massive Cardiac Adiposity (Floating Heart) in the Native Hearts of Patients Having Heart Transplantation at a Single Texas Hospital (2013 to 2015) and Comparison of Various Clinical and Morphologic Variables in the Patients With Massive Versus Nonmassive Cardiac Adiposity. The American Journal of Cardiology 2016; 117(8): 1375-1380.

Massive Diffuse Calcification of the Ascending Aorta and Minimal Focal Calcification of the Abdominal Aorta in Heterozygous Familial Hypercholesterolemia.

Roberts WC, Won VS, Weissenborn MR, Khalid A, Lima B. Massive Diffuse Calcification of the Ascending Aorta and Minimal Focal Calcification of the Abdominal Aorta in Heterozygous Familial Hypercholesterolemia. American Journal of Cardiology 2016; 117(8): 1381-1385.

Atrophy of the Heart After Insertion of a Left Ventricular Assist Device and Closure of the Aortic Valve.

Roberts WC, Hall SA, Ko JM, McCullough PA, Lima B. Atrophy of the Heart After Insertion of a Left Ventricular Assist Device and Closure of the Aortic Valve. American Journal of Cardiology 2016; 117(5): 878-879.

Mitral Valve Replacement After Failed Mitral Ring Insertion With or Without Leaflet/Chordal Repair for Pure Mitral Regurgitation.

Roberts WC, Moore M, Ko JM, Hamman BL. Mitral Valve Replacement After Failed Mitral Ring Insertion With or Without Leaflet/Chordal Repair for Pure Mitral Regurgitation. The American Journal of Cardiology 2016; 117(11): 1790-1807.

Contemporary extracorporeal membrane oxygenation therapy in adults: Fundamental principles and systematic review of the evidence.

Squiers JJ, Lima B, DiMaio JM. Contemporary extracorporeal membrane oxygenation therapy in adults: Fundamental principles and systematic review of the evidence. The Journal of Thoracic and Cardiovascular Surgery 2016; Epub.
For full article, click here.

Surgery for acquired cardiac disease: An evolving paradigm with a promising future.

Whitson BA, Lima B. Surgery for acquired cardiac disease: An evolving paradigm with a promising future. The Journal of Thoracic and Cardiovascular Surgery 2016; 151(6): 1466-1469.

For an archived listing of past articles, please click here.

To learn more about our clinical trials or to enroll, please call 1.800.4BAYLOR or visit our online trial listing.

In addition to research, a number of educational publications are available to you and your family. Our Community Resource Center in the Baylor Heart and Vascular Institute—located on the ground floor of the hospital—offers a wealth of information about cardiovascular disease management and prevention. We have Internet access, interactive medical education programs, and more. Please come visit us.

Top of Page


Developed and Hosted by NorthPoint Domain
©Copyright 2017. NorthPoint Domain Inc. All Rights Reserved

Warning

Your Session will expire in 5 minutes

Please click the "Continue Session" button below to continue using the website. To end your session please click the "End Session" button below. After 5 minutes of inactivity your session will be terminated and you will be required to log in again.